Review about Zopiclone

This page shows detailed information about a specific medicine review.


04/06/2022 | | 46moderated by Philip
zopiclone (7,5MG) for Insomnia

I started taking Zopiclone to relieve insomnia as an alternative to benzos (which had left me feeling groggy, numb and unable to think or focus). I took half a tablet most nights, and generally enjoyed good nights' sleep, and woke feeling refreshed and rested (again, unlike benzos). As an additional benefit, it eliminated my anxiety. I stopped taking Zopiclone after 18 months, with NO withdrawal symptoms or negative side effects, my anxiety gone, and enjoying long and restful sleeps. I noticed NIL negative side effects from taking this drug over such an extended period of time, except maybe occasional short-term memory loss, which could also be attributed to age. I am usually anti-medication, but Zopiclone has been a wonder drug for me, and I highly recommend it for therapeutic use as a supplement to mindfulness.

0 reactions

Reactions to this review

No reactions found at this moment.

The list of reactions to this review is empty. Please check back later.

The content on this page is user-generated content, read and revised before approval to comply with our standards for a medicine review or reaction. We do not enforce any proven medical knowledge from our users to allow them to present their experiences. This way, the opinions and experiences described state only the views of the writers and not those of the owner of this website. Remember that these experiences differ from person to person and that you should always contact your doctor or pharmacist for advice on medication.

Add your reaction to this review

IMPORTANT: this email address is from the person giving this reaction and will be kept private. It will only be used by us to contact you about your reaction or if you check the option below.

Copyright © 2008-2024 Insight Pharma Services BV.
All rights reserved.
Most icons from FontAwesome. Some icons made by Prosymbols from and licensed as CC 3.0 BY.